▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

David Haen

XMFHaen

Recent Articles by David Haen

Stethascope

Oct 9, 2019 by David Haen

3 Companies To Watch For At November’s Society for Immunotherapy of Cancer Meeting

Due to the explosion in immuno-oncology in recent years, what was once a small scientific meeting near the end of the year has become a go-to event for drug developers.

Qiagen scientist

Oct 8, 2019 by David Haen

Is Qiagen’s Stumble An Opportunity For Investors?

Investors are wondering whether to welcome or fear Qiagen’s recent announcement about its CEO’s departure, slowing sales, and business restructuring.

louis-reed-pwcKF7L4-no-unsplash

Oct 8, 2019 by David Haen

Are These 3 Recent Biotech IPOs a Good Deal for Investors?

Three biotech companies successfully completed IPOs last week. Would investors have been better off buying shares on the open market?

stock quotes on digital display -- ticker index exchange

Oct 4, 2019 by David Haen

3 Mid-Cap Biotech Stocks To Consider Buying Now

These revenue-producing, possible acquisition candidates may be the right medicine to heal your portfolio.

stock chart

Oct 2, 2019 by David Haen

Are There Good Investments Among 2019's Biotech IPOs?

Investing in biotechs is inherently risky. IPOs are too. What does the stock performance of 2019’s biotech IPO class look like so far?

Oct 1, 2019 by David Haen

A Cancer Diagnostics Company You Should Own Today

Since the start of September, the luster has disappeared from Exact Sciences' stock. This pullback provides an opportunity to own a company that is growing on multiple levels.

bottles of prescription medicine sitting on shelves in cabinet drugs pills

Sep 30, 2019 by David Haen

2 Biotechs Tackling the Challenge of Lou Gehrig’s Disease

Historically, the underlying cause of ALS has evaded researchers, except in rare genetic cases. But more light has been shone on the disease and the potential of new avenues for drug intervention.

ousa-chea-gKUC4TMhOiY-unsplash

Sep 27, 2019 by David Haen

Cancer Results to Watch at This Weekend’s European Society of Medical Oncology Congress

Doctors, researchers, and pharmaceutical experts will converge upon Barcelona to share the latest results in cancer research. Here is a run-down on three to watch.

GettyImages-1126114906

Sep 25, 2019 by David Haen

4 Mid-Market Banks Powering Advancements In Healthcare

Innovation needs capital. Discovering and developing new medicines requires lots of it. Let's explore a few investment banks helping to fund these advancements.

GettyImages-1088363616

Sep 20, 2019 by David Haen

6 September Healthcare IPOs Investors Should Take Stock Of

The recent crop of new stocks runs the gamut from R&D stage biotech to a Fortune 500 spin-off with billions in revenue.

GettyImages-1082433942

Sep 19, 2019 by David Haen

3 Ways to Gain Exposure to Venture Capital in Tech and Healthcare

Investing in companies that provide growth capital to promising start-ups can be financially rewarding.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services